COVID-19 vaccine Corbevax receives Drug Controller General's approval for Emergency Use Authorization
Sakshi Education
Another indigenous COVID-19 vaccine Corbevax has received the Drug Controller General of India's approval for Emergency Use Authorization. Corbevax is developed by Biological-E Limited, which is India’s first indigenously developed Receptor Binding Domain protein sub-unit vaccine for COVID-19.
COVID-19 vaccine Corbevax receives Drug Controller General's approval for Emergency Use Authorization
The Department of Biotechnology and its Public Sector Undertaking, Biotechnology Industry Research Assistance Council (BIRAC), have supported Biological-E’s COVID-19 vaccine candidate from pre-clinical stage to Phase-III clinical studies.
The vaccine candidate was provided financial support under COVID-19 Research Consortium through the National Biopharma Mission. Later, support was provided under Mission COVID Suraksha for clinical development.
Corbevax is a 2-dose vaccine administered intramuscularly and can be stored at 2ºC to 8ºC.
